ArticleFrontiers in pharmacology2025

Kai-Xin-San ameliorates mild cognitive impairment in SAMP8 mice by inhibiting neuroinflammation and pyroptosis via NLRP3/Caspase-1 pathway modulation.

Shu Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.